These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 815983)

  • 21. [In vivo and in vitro susceptibility of Trypanosoma cruzi to ketoconazole].
    Rubiolo ER; Cano RC
    Rev Latinoam Microbiol; 1987; 29(4):395-401. PubMed ID: 3149794
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunobiological characterization of a presumed atypical strain of Trypanosoma cruzi].
    Muller LA; de Isola EL; Quintana RD; González Cappa SM
    Medicina (B Aires); 1987; 47(2):139-44. PubMed ID: 3121978
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of chagas infection caused by an atypical strain of Trypanosoma cruzi in a newborn infant].
    de Storni P; Bakos E; Bustamante A; Vanioff JA
    Medicina (B Aires); 1984; 44(3):287-91. PubMed ID: 6443628
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the therapeutic activity of fluconazole in acute experimental infection caused by Trypanosoma cruzi].
    Campos R; Amato Neto V; Moreira AA; de Souza HB; Okumura M; Pinto PL; Braz LM; Silva MF; Matsubara L
    Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(4):174-5. PubMed ID: 1340597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental and preliminary observation on the ultimate influence of cyclosporin on chronic infection of mice by Trypanosoma cruzi].
    Amato Neto V; Moreira AA; Campos R; Duarte MI; Pinto PL; de Sant'Ana EJ
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):219-21. PubMed ID: 3108993
    [No Abstract]   [Full Text] [Related]  

  • 26. [(Effect of Lampit on experimental Trypanosoma cruzi infection in mice)].
    Apt W; Mancilla R; Díaz M; Díaz S
    Bol Chil Parasitol; 1972; 27(3):80-6. PubMed ID: 4196829
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the efficacy of nifurtimox in chronic human chagasic infection by using xenodiagnosis (author's transl)].
    Cerisola JA; Neves da Silva N; Prata A; Schenone H; Rohwedder R
    Bol Chil Parasitol; 1977; 32(3-4):51-62. PubMed ID: 416834
    [No Abstract]   [Full Text] [Related]  

  • 28. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
    Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
    Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New process for screening of drugs in experimental infection with Trypanosoma cruzi].
    Campos R; Amato Neto V; de Souza HB; Braz LM
    Rev Inst Med Trop Sao Paulo; 1991; 33(4):325-7. PubMed ID: 1844956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Exp Parasitol; 1998 Jun; 89(2):251-6. PubMed ID: 9635449
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
    Villarreal D; Barnabé C; Sereno D; Tibayrenc M
    Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.
    Lo Presti MS; Rivarola HW; Bustamante JM; Fernández AR; Enders JE; Fretes R; Gea S; Paglini-Oliva PA
    Int J Antimicrob Agents; 2004 Jun; 23(6):634-6. PubMed ID: 15194137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi: a pharmacological comparison of some Bolivian isoenzymic strains.
    Barnabe C; Tibayrenc M; Dujardin JP
    Ann Soc Belg Med Trop; 1983 Dec; 63(4):319-24. PubMed ID: 6198978
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of nifurtimox on Trypanosoma cruzi in tissue cultures.
    Gönnert R; Bock M
    Arzneimittelforschung; 1972 Sep; 22(9):1582-6. PubMed ID: 4567080
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
    Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of lampit on Trypanosoma cruzi in mice organs and in the bloodstream.
    Villalta F; de Souza W; Leon W
    Z Parasitenkd; 1979; 61(1):21-7. PubMed ID: 120645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of drug sensitivities of three strains of Trypanosoma cruzi in inbred A/Jax mice.
    Cover B; Gutteridge WE
    Trans R Soc Trop Med Hyg; 1981; 75(2):274-81. PubMed ID: 6795771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo activity of certain thiosemicarbazones against Trypanosoma cruzi.
    Wilson HR; Revankar GR; Tolman RL
    J Med Chem; 1974 Jul; 17(7):760-1. PubMed ID: 4209583
    [No Abstract]   [Full Text] [Related]  

  • 39. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection.
    dos Santos DM; Talvani A; Guedes PM; Machado-Coelho GL; de Lana M; Bahia MT
    Exp Parasitol; 2009 Jan; 121(1):8-14. PubMed ID: 18848935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.